Preclinical application of radioimmunoguided surgery using anti-carcinoembryonic antigen biparatopic antibody in the colon cancer

European Surgical Research

Volumn 37, Issue 1, 2005, Pages 36-44

  Kim, J C ^a   Roh, S A ^a   Koo, K H ^a   Cho, Y K ^a   Kim, H C ^a   Yu, C S ^a   Oh, S J ^a,b   Ryu, J S ^a,b   Bicknell, D C ^c,d   Bodmer, W F ^c,d  

^a University of Ulsan College of Medicine   (South Korea)

^b Asan Institute for Life Sciences   (South Korea)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Biparatopic antibody; Carcinoembryonic antigen; Colorectal cancer; PR1A3; Radioimmunoguided surgery; T84.66

Indexed keywords

ANTIBODY; BIPARATOPIC ANTIBODY; CARCINOEMBRYONIC ANTIBODY; IODINE 125; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; COLON CANCER; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; HUMAN; LABORATORY DIAGNOSIS; LYMPH NODE; PRIORITY JOURNAL; RADIATION DETECTION; RADIOACTIVITY; RADIOIMMUNOGUIDED SURGERY;

ANTIBODIES; AUTORADIOGRAPHY; CARCINOEMBRYONIC ANTIGEN; CARCINOMA; COLONIC NEOPLASMS; EPITOPES; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MIDDLE AGED; RADIOIMMUNODETECTION;

EID: 20944435847     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083146     Document Type: Article

References (34)

1. Galandiuk S, Wieand HS, Moertel CG, Cha SS, Fitzgibbons RJ Jr, Pemberton JH, Wolff BG: Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet 1992;174:27-32.
2. Avital S, Haddad R, Troitsa A, Kashtan H, Brazovsky E, Gitstein G, Skornick Y, Schneebaum S: Radioimmunoguided surgery for recurrent colorectal cancer manifested by isolated CEA elevation. Cancer 2000;15:1692-1698.
3. 123I-radiolabled monoclonal antibody CC49. Cancer 1996;77:613-620.
4. Manayan RC, Hart MJ, Friend WG: Radioimmunoguided surgery for colorectal cancer. Am J Surg 1997;173:386-389.
5. Martin EW Jr: Radioimmunoguided Surgery in the Detection and Treatment of Colorectal Cancer, ed 1. Austin, Landes, 1994.
6. 125I-labeled carcinoembryonic antigen-specific monoclonal antibody submucosally. Dis Colon Rectum 2003;46:1659-1666.
7. Stalteri MA, Mather SJ: A cross-linked monoclonal antibody fragment for improved tumor targeting. Bioconjug Chem 1995;6:179-186.
8. Roselli M, Guadagni F, Buonomo O, Belardi A, Vittorini V, Cavazzana A, Spagnoli LG, Cipriani C, Casciani CU: Intraoperative radioimmunolocalization of an anti-CEA MAb F(Ab′)2 (FO23C5) in CEA serum-negative colorectal cancer patients. Anticancer Res 1996;16:883-889.
9. Mayer A, Tsiompanou E, O'Malley D, Boxer GM, Bhatia J, Flynn AA, Chester KA, Davidson BR, Lewis AA, Winslet MC, Dhillon AP, Hilson AJ, Begent RH: Radioimmunoguided surgery in colorectal cancer using a genetically engineered anti-CEA single-chain Fv antibody. Clin Cancer Res 2000;6:1711-1719.
10. Rheinnecker M, Hardt C, Ilag LL, Kufer P, Gruber R, Hoess A, Lupas A, Rottenberger C, Pluckthun A, Pack P: Multivalent antibody fragments with high functional affinity for a tumor-associated carbohydrate antigen. J Immunol 1996;157:2989-2997.
11. Yazaki PJ, Wu AM, Tsai SW, Williams LE, Ikler DN, Wong JY, Shively JE, Raubitschek AA: Tumor targeting of radiometal labeled anti-CEA recombinant T84.66 diabody and t84.66 minibody: Comparison to radioiodinated fragments. Bioconjug Chem 2001;12: 220-228.
12. Goel A, Colcher D, Baranowska-Kortylewicz J, Augustine S, Booth BJ, Pavlinkova G, Batra SK: Genetically engineered tetravalent single-chain Fv of the pancarcinoma monoclonal antibody CC49:improved biodistribution and potential for therapeutic application. Cancer Res 2000;60:6964-6971.
13. Sachlom J: Basic principles and applications of monoclonal antibodies in the management of carcinomas: The Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 1986;46:3225-3238.
14. Robert B, Dorvillius M, Buchegger F, Garambois V, Mani JC, Pugnères M, Mach JP, Pèlegrin A: Tumor targeting with newly designed biparatopic antibodies directed against two different epitopes of the carcinoembryonic antigen. Int J Cancer 1999;81:285-291.
15. Kim JC, Roh SA, Koo KH, Ryu JH, Hong HK, Oh SJ, Ryu JS, Kim HJ, Bodmer WF: Enhancement of colorectal tumor targeting using a novel biparatopic monoclonal antibody against carcinoembryonic antigen in experimental radioimmunoguided surgery. Int J Cancer 2002;97:542-547.
16. Kim JC, Kim WS, Ryu JS, Oh SJ, Lee DH, Koo KH, Roh SA, Kim HC, Yu CS, Kang GH, Bodmer WF: Applicability of carcinoembryonic antigen-specific monoclonal antibodies to radioimmunoguided surgery for human colorectal carcinoma. Cancer Res 2000;60:4825-4829.
17. Yorke ED, Beaumier PL, Wessels BW, Fritzberg AR, Morgan AC Jr: Optimal antibody-radionuclide combinations for clinical radioimmunotherapy: A predictive model based on mouse pharmacokinetics. Nucl Med Biol 1991; 18:827-835.
18. Dewanjee MK: Radiation: Therapy, Practice and Biomedical Application, ed 1, New York, Kluwer, 1992.
19. Abdel-Nabi HH, Levine G, Lamki LM, Murray JL, Tauxe WN, Shah AN, Patt YZ, Doerr RJ, Klein HA, Gona J: Colorectal carcinoma metastases: Detection with In-111-labeled monoclonal antibody CCR 086. Radiology 1990;176:117-122.
20. Durbin H, Young S, Stewart LM, Wrba F, Rowan AJ, Snary D, Bodmer WF: An epitope of carcinoembryonic antigen defined by clinically relevant antibody PR1A3. Proc Natl Acad Sci USA 1994;91:4313-4317.
21. 111In-labelled monoclonal antibody against carcinoembryonic antigen in colorectal cancer and of some biological factors affecting its uptake. Int J Colorectal Dis 1989;4:97-108.
22. Neri D, Momo M, Prospero T, Winter G: High-affinity antigen binding by chelating recombinant antibodies. J Mol Biol 1995;246: 367-373.
23. 2 antibody containing thioetherlinked Fab fragments. J Immunol 1987;139: 2367-2375.
24. 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5fluorouracil in patients with metastatic colorectal cancer. Clin Cancer Res 2003;9: 5842-5852.
25. Harlow E, Lane D: Antibodies, ed 1. New York, Cold Spring Harbor Laboratory, 1988.
26. Yokota T, Milenic DE, Whitlow M, Wood JF, Hubert SL, Schlom J: Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms. Cancer Res 1993;53:3776-3783.
27. Murakami M, Kuroki M, Arakawa F, Haruno M, Kuwahara M, Ozaki H, Senba T, Matsuoka Y: Binding reactivity of monoclonal anti-carcinoembryonic antigen (CEA) antibodies with cell membrane-bound CEA and with free CEA in solution. Immunol Invest 1996;25:23-35.
28. Pack P, Pluckthun A: Miniantibodies: Use of amphipathic helices to produce functional, flexibly linked dimeric FV fragments with high avidity in Escherichia coli. Biochemistry 1992; 31:1579-1584.
29. 99mTc PR1A3 monoclonal antibody. Tumori 1995;81(suppl):107-108.
30. Wong JY, Thomas GE, Yamauchi D, Williams LE, Odom-Maryon TL, Liu A, Esteban JM, Neumaier M, Dresse S, Wu AM, Primus FJ, Shively JE. Raubitschek AA: Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody. J Nucl Med 1997;38: 1951-1959.
31. Cornelius EA, West AB: False tumor-positive lymph nodes in radioimmunodiagnosis and radioimmunoguided surgery: Etiologic mechanisms. J Surg Oncol 1996;63:23-35.
32. Roselli M, Buonomo O, Piazza A, Guadagni F, Vecchione A, Brunetti E, Cipriani C, Amadei G, Nieroda C, Greiner JW, Casciani CU: Novel clinical approaches in monoclonal antibody-based management in colorectal cancer patients: Radioimmunoguided surgery and antigen augmentation. Semin Surg Oncol 1998;15:254-262.
33. DeNardo SJ, Kroger LA, DeNardo GL: A new era for radiolabeled antibodies in cancer? Curr Opin Immunol 1999;11:563-569.
34. Ford CH, Osborne PA, Rego BG, Mathew A: Bispecific antibody targeting of doxorubicin to carcinoembryonic antigen-expressing colon cancer cell lines in vitro and in vivo. Int J Cancer 2001;92:851-855.